Phenotypes Associated with This Genotype

Genotype
MGI:3770618

• Allelic Composition: Dmtf1^tm1Cjs/Dmtf1^tm1Cjs; Kras^tm3Tyj/Kras⁺
• Genetic Background: involves: 129S4/SvJae * C57BL/6

• ♀: phenotype observed in females
• ♂: phenotype observed in males
• N: normal phenotype

mortality/aging

premature death ( J:126002 )

• mean survival time of double mutants is 21 weeks compared to 35 weeks for Kras^+/-, Dmtf1-sufficient mice

neoplasm

increased T cell derived lymphoma incidence ( J:126002 )

• ~20% of mice develop thymic lymphomas

increased skin papilloma incidence ( J:126002 )

• 10-20% of animals develop tail papillomas

increased lung tumor incidence ( J:126002 )

increased lung adenoma incidence ( J:126002 )

• all mice develop lung adenomas or lung adenocarcinomas

increased lung adenocarcinoma incidence ( J:126002 )

• greater than 50% of mice develop lung carcinomas by 40 weeks of age, and tumors are significantly larger than those found in Kras^LA+/- single mutants

• number of tumor nodules increase as animals become sick, with trend to increased nodule size

decreased tumor latency ( J:126002 )

• tumorigenesis is accelerated relative to heterozygous Kras, wild-type Dmtf1 mice

integument

increased skin papilloma incidence ( J:126002 )

• 10-20% of animals develop tail papillomas

endocrine/exocrine glands

increased T cell derived lymphoma incidence ( J:126002 )

• ~20% of mice develop thymic lymphomas

respiratory system

increased lung tumor incidence ( J:126002 )

increased lung adenoma incidence ( J:126002 )

• all mice develop lung adenomas or lung adenocarcinomas

increased lung adenocarcinoma incidence ( J:126002 )

• greater than 50% of mice develop lung carcinomas by 40 weeks of age, and tumors are significantly larger than those found in Kras^LA+/- single mutants

• number of tumor nodules increase as animals become sick, with trend to increased nodule size

immune system

increased T cell derived lymphoma incidence ( J:126002 )

• ~20% of mice develop thymic lymphomas

hematopoietic system

increased T cell derived lymphoma incidence ( J:126002 )

• ~20% of mice develop thymic lymphomas